CRISPR/Cas9 technology introduced histidine to alanine and glutamate to alanine point mutations at positions 1388 (H1288A) and 1290 (E1390A) in the Jmjc domain. These point mutations produce a demethylase dead protein. (J:328273)
查看原文 参与反馈
CRISPR/Cas9 technology introduced histidine to alanine and glutamate to alanine point mutations at positions 1388 (H1288A) and 1290 (E1390A) in the Jmjc domain. These point mutations produce a demethylase dead protein. (J:328273)